Paper Details
- Home
- Paper Details
Original Abstract of the Article :
Famotidine is of interest as a possible treatment for COVID-19, with effects on disease-related symptoms and survival reported in observational and retrospective studies, as well as <i>in silico</i> predictions of binding to potential SARS-CoV-2 drug targets. Published studies of famotidine for COVI...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786260/
データ提供：米国国立医学図書館（NLM）
Famotidine: A Potential Oasis in the Desert of COVID-19 Neuropsychiatric Symptoms
The COVID-19 pandemic has unleashed a torrent of challenges, creating a desert of uncertainty and fear. This case study explores the potential role of famotidine, a commonly used heartburn medication, in treating neuropsychiatric symptoms following COVID-19 infection. The authors present a compelling case of an 18-year-old man who experienced significant depression, anxiety, and cognitive impairments after a mild case of COVID-19. They describe the remarkable improvement in his symptoms after initiating treatment with famotidine, suggesting a potential therapeutic role for this readily available drug.
Famotidine: A Potential Oasis for Post-COVID-19 Neuropsychiatric Symptoms
This study offers a glimmer of hope in the desert of post-COVID-19 neuropsychiatric complications. While further research is needed to confirm these findings, the case report provides compelling evidence for the potential therapeutic benefits of famotidine in addressing these debilitating symptoms. This research highlights the need for a comprehensive understanding of the long-term effects of COVID-19, particularly the neuropsychiatric sequelae.
A Camel's Takeaway: Navigating the Shifting Sands of Post-COVID-19 Complications
The COVID-19 pandemic has brought to light the complex and multifaceted nature of this virus. This case study underscores the importance of recognizing and addressing the long-term neuropsychiatric consequences of infection. The authors provide a valuable case report that sheds light on a potential therapeutic avenue for managing these symptoms.
Dr.Camel's Conclusion
This case study suggests that famotidine may be a potential therapeutic option for treating neuropsychiatric symptoms following COVID-19 infection. Further research is needed to confirm these findings and explore the underlying mechanisms of action. It highlights the need for a comprehensive understanding of the long-term effects of COVID-19, particularly the neuropsychiatric sequelae.
Date :
- Date Completed n.d.
- Date Revised 2021-01-12
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.